Costa Alexandra C, Santos Joana M O, Medeiros-Fonseca Beatriz, Oliveira Paula A, Bastos Margarida M S M, Brito Haissa O, Gil da Costa Rui M, Medeiros Rui
Molecular Oncology and Viral Pathology Group, Research Center of IPO Porto (CI-IPOP)/RISE@CI-IPOP (Health Research Network), Portuguese Oncology Institute of Porto (IPO Porto), Porto Comprehensive Cancer Center (Porto.CCC), 4200-072 Porto, Portugal.
Faculty of Medicine of the University of Porto (FMUP), 4200-319 Porto, Portugal.
Cancers (Basel). 2022 Apr 28;14(9):2216. doi: 10.3390/cancers14092216.
High-risk human papillomavirus (HPV) is the etiologic agent of several types of cancer. Mast cells’ role as either a driving or opposing force for cancer progression remains controversial. MicroRNAs are dysregulated in several HPV-induced cancers, and can influence mast cell biology. The aim of this study was to evaluate mast cell infiltration and to identify microRNAs potentially regulating this process. Transgenic male mice (K14-HPV16; HPV+) and matched wild-type mice (HPV−) received 7,12-Dimethylbenz[a]anthracene (DMBA) (or vehicle) over 17 weeks. Following euthanasia, chest skin and ear tissue samples were collected. Mast cell infiltration was evaluated by immunohistochemistry. MicroRNAs associated with mast cell infiltration were identified using bioinformatic tools. MicroRNA and mRNA relative expression was evaluated by RT-qPCR. Immunohistochemistry showed increased mast cell infiltration in HPV+ mice (p < 0.001). DMBA did not have any statistically significant influence on this distribution. Ear tissue of HPV+ mice showed increased mast cell infiltration (p < 0.01) when compared with chest skin samples. Additionally, reduced relative expression of miR-125b-5p (p = 0.008, 2−ΔΔCt = 2.09) and miR-223-3p (p = 0.013, 2−ΔΔCt = 4.42) seems to be associated with mast cell infiltration and increased expression of target gene Cxcl10. These results indicate that HPV16 may increase mast cell infiltration by down-regulating miR-223-3p and miR-125b-5p.
高危型人乳头瘤病毒(HPV)是多种癌症的病原体。肥大细胞在癌症进展中是驱动因素还是对抗因素,其作用仍存在争议。微小RNA在几种HPV诱导的癌症中表达失调,并可影响肥大细胞生物学特性。本研究的目的是评估肥大细胞浸润情况,并鉴定可能调控这一过程的微小RNA。转基因雄性小鼠(K14-HPV16;HPV阳性)和配对的野生型小鼠(HPV阴性)在17周内接受7,12-二甲基苯并[a]蒽(DMBA)(或赋形剂)。安乐死后,收集胸部皮肤和耳部组织样本。通过免疫组织化学评估肥大细胞浸润情况。使用生物信息学工具鉴定与肥大细胞浸润相关的微小RNA。通过RT-qPCR评估微小RNA和mRNA的相对表达。免疫组织化学显示HPV阳性小鼠的肥大细胞浸润增加(p<0.001)。DMBA对这种分布没有任何统计学上的显著影响。与胸部皮肤样本相比,HPV阳性小鼠的耳部组织显示肥大细胞浸润增加(p<0.01)。此外,miR-125b-5p(p=0.008,2−ΔΔCt=2.09)和miR-223-3p(p=0.013,2−ΔΔCt=4.42)相对表达的降低似乎与肥大细胞浸润及靶基因Cxcl10表达增加有关。这些结果表明,HPV16可能通过下调miR-223-3p和miR-125b-5p来增加肥大细胞浸润。